Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Aug-24 4:11 PM View:  | Acrivon Therapeutics, Inc. (ACRV) | 21-Aug-24 | Payment of Exercise | 79,616 | $9.19 | $731,671.00 | (3%) 2.82M to 2.74M | |
| 16-Aug-24 4:47 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 59,765 | $7.02 | $419,550.00 | (2%) 2.88M to 2.82M | |
| 16-May-24 6:54 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 54,918 | $8.36 | $459,114.00 | (2%) 2.93M to 2.88M | |
| 16-Feb-24 5:06 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 41,861 | $3.40 | $142,327.00 | (1%) 2.98M to 2.94M | |
| 16-Nov-23 7:41 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 239,023 | $5.08 | $1,214,240.00 | (7%) 3.22M to 2.98M | |
| 23-Aug-23 4:19 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 21-Aug-23 | Grant | 493,994 | -- | -- | 18% 2.72M to 3.22M | |
| 01-Jun-23 8:40 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 31-May-23 | Option Exercise | 33,605 | $3.88 | $130,387.00 | 1% 2.69M to 2.72M | |
| 16-Nov-22 7:05 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant | 1,498,240 | -- | -- | 129% 1.17M to 2.66M | |
| 16-Nov-22 7:05 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant Duplicate | 26,707 | -- | -- | 1% 2.66M to 2.69M |